The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia

Laryngoscope

Volumn 106, Issue 1 I, 1996, Pages 86-92

  Sedory Holzer, Susan E ^a,b   Ludlow, Christy L ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^b MEDSTAT GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; DYSPHAGIA; DYSPHONIA; FEMALE; HUMAN; HYOID BONE; LARYNX MUSCLE; MALE; PRIORITY JOURNAL; SWALLOWING;

ADULT; BOTULINUM TOXINS; DEGLUTITION DISORDERS; ELECTROMYOGRAPHY; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; LARYNX; MALE; MIDDLE AGED; MOVEMENT; SPASM; VOICE DISORDERS;

EID: 0030046196     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199601000-00017     Document Type: Article

References (20)

1. Clinical use of botulinum toxin. NIH Consensus Development Conference Consensus Statement. Vol. 8, Bethesda, Md.: National Institutes of Health, 1990:1-20.
2. Ludlow CL, Naunton RF, Sedory SE, et al. Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia. Neurology 1988;38:1220-1225.
3. Ludlow CL, Bagley JA, Yin SG, et al. A comparison of different injection techniques in the treatment of spasmodic dysphonia with botulinum toxin. J Voice 1992;6:380-386.
4. Kitzing P, Lofquist A. Teflon paste injection into the paralytic vocal fold. Scand J Respir Dis 1977;58:197-204.
5. Froeschels E, Kastein S, Weiss DA. A method of therapy for paralytic conditions of the mechanisms of phonation, respiration and glutination. J Speech Hear Dis 1955;20:365-370.
6. Dedo HH, Izdebski K. Problems with surgical (RLN section) treatment of spastic dysphonia. LARYNGOSCOPE 1983;93: 268-271.
7. Aronson AE, De Santo LW. Adductor spasmodic dysphonia: three years after recurrent laryngeal nerve section. LARYNGOSCOPE 1983;93:1-8.
8. Logemann JA. Swallowing physiology and pathophysiology. Otolaryngol Clin N orthAm 1988;21:613-623.
9. Sorin R, McClean MD, Ezerzer F, et al. Electroglottographic evaluation of the swallow. Arch Phys Med Rehabil 1987;68: 232-235.
10. Childers DG, Krishnamurthy AK. A critical review of elec-troglottography. Crit Rev Biomed Eng 1985;12:131-161.
11. Sonies BS, Parent LJ, Morrish K, et al. Durational aspects of the oral pharyngeal phase of swallow in normal adults. Dysphagia 1988;3:1-10.
12. Blonsky E, Logemann J, Boshes B, et al. Comparison of speech and swallowing function in patients with tremor disorders and normal geriatric patients: a cineflourographic study. JGerontol 1975;30:299-303.
13. Mandelstam P, Lieber A. Cineradiographic evaluation of the esophagus in normal adults. Gastroenterology 1970;58:32-38.
14. Reimers-Neils L, Logemann J, Larson C. Viscosity effects on EMG activity in normal swallow. Dysphagia 1994;9:101-106.
15. Gay T, Rendell JK, Spiro J. Oral and laryngeal muscle coordination during swallowing. LARYNGOSCOPE 1994;104:341-349.
16. Blitzer A, Brin MF, Fahn S, et al. Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia). LARYNGOSCOPE 1988;98:193-197.
17. Ludlow CL, Hallett M, Sedory SE, et al. The pathophysiology of spasmodic dysphonia and its modification by botulinum toxin. In: Berardelli A, Benecke R, Manfredi M, et al., eds. Motor Disturbances. 2nd ed. Orlando, Fla.: Academic Press, 1990:274-288.
18. Ludlow CL, Baker M, Naunton RF, et al. Intrinsic laryngeal muscle activation in spasmodic dysphonia. In: Benecke R, Conrad B, Marsden CD, eds. Motor Disturbances. Orlando, FIa.: Academic Press, 1988:119-130.
19. Ludlow CL, Connor NP. Dynamic aspects of phonatory control in spasmodic dysphonia. J Speech Hear Res 1987;30:197-206.
20. Schaefer SD. Neuropathology of spasmodic dysphonia. LARYNGOSCOPE 1983;93:1183-1204.